Navigation Links
Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
Date:4/23/2008

p>"Lying to the federal government is a serious felony that obstructs the law enforcement process," said Thomas O. Barnett, Assistant Attorney General in charge of the Department's Antitrust Division. "The Department of Justice will vigorously prosecute such illegal activity."

Plavix, a patented pharmaceutical, is the most widely prescribed blood-thinning drug in the world. Approximately 48 million Americans take Plavix daily to prevent potentially fatal blood clots. The drug was approved for sale in the U.S. in November 1997.

BMS, an international pharmaceutical company headquartered in New York, N.Y, participates in the sale and marketing of Plavix in the U.S. through the Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership, which sold more than $3.5 billion of Plavix in the U.S. in 2005.

Bodnar is charged with a violation of the Federal False Statements Act, which carries a maximum sentence of five years of imprisonment and a fine of $250,000. The fine may be increased to twice the gain from the offense or twice the loss incurred by the victims of the crime.

This case is part of an ongoing investigation being conducted by the Antitrust Division's National Criminal Enforcement Section and the New York Field Office of the Federal Bureau of Investigation. Anyone with information about this matter should contact the Antitrust Division's National Criminal Enforcement Section at 202-307-6694.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
2. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Former State Representative Terry Parke Joins Secure Services Corp.
5. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
6. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Countrys Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National Moment Of Change Intervention Conference:
7. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
8. Former HHS Secretary Dr. Louis Sullivan, Lt. Gov. Cagle Address Need to Improve Quality of Patient Care
9. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
10. Nobel Honors 3 Former March of Dimes Prize Recipients
11. Over one-third of former American football players had sexual relations with men, study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ntists have conducted a study, the first of its ki...he experiment was performed on mice, yet scientist.... The cause for Type 2 diabetes is still unknow... this. Yet one of the features of this disease is...
...archers at UT Southwestern Medical Center have fou...n inducing hypertension. "We have discovered that...f the risk of hypertension, it actually induces hy...asin, associate professor of internal medicine and...
...ious studies have shown that inflammation may some...alignant. UCSF scientists// have now discovered wh...cally, the "innate" immune system's Pac-Man-like w...and destroy invading microbes when receptors on th...
...archers at San Antonio's South Texas Center for Em...onio Health Science Center// (UTHSC) have come tog...hat will prevent Chlamydia. Chlamydia is a common...y the bacterium, Chlamydia trachomatis, which can ...
Other Medicine News:Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:C-Reactive Protein Induces Hypertension 2Health News:Inflammation can Lead to Cancer 2Health News:A Combined Research for Producing Chlamydia Vaccine Begins 2
(Date:8/19/2008)...swire-FirstCall/ -- Vical Incorporated,(Nasdaq: V...h the Karolinska,Institutet (KI), a leading Europe...or Infectious Disease Control (SMI), a governmenta...adjuvant with the Biojector(R),2000 needle-free in...,OTCBB: BJCT) for a multivalent preventive DNA vac...
(Date:8/19/2008)... /- VION,PHARMACEUTICALS, I...d,entered into an agreement with the Dutch-Belgian...the "HOVON") to conduct a clinical trial of,laromu...emission-induction,therapy in patients aged 18-65 ...ia (AML) and high-risk myelodysplasia (MDS)., Ala...
(Date:8/18/2008).../PRNewswire-USNewswire/ -- Due to an,exceptionally...s in,southeastern Pennsylvania, the Department of ...ill be stepping up efforts this week to combat the...ely to carry -- the virus., While only one human ...s year (a 27-year-old Montgomery County woman), DE...
(Date:8/18/2008)...re-USNewswire/ -- Boston University and Aubrey,Mil... Human Genetics, Inc.,("CHG") and Director of the ...nounced that CHG will no longer offer testing serv...tics, Inc., These patented tests include tests re... or Connexin 26 mutations, developmental disorders...
Breaking Medicine Technology:Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 1Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 2Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 3Gene mutation improves leukemia drugs effect 22091 1Gene mutation improves leukemia drugs effect 22091 2People with lower incomes lower education levels have higher death rates 22089 1People with lower incomes lower education levels have higher death rates 22089 2Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 1Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 2
..., 2007 /PRNewswire-FirstCall/ --,SuperGen Inc. ann...ons at the American Association for Cancer Researc...ese presentations,will focus on data concerning ma...ng its lead tyrosine kinase inhibitor compound,MP...target involved,in cancer cell drug resistance. Pr...
... 2007 -- CytImmune, a,clinical stage nanomedicine...ization of multifunctional, tumor-targeted therapi...at the 43rd American,Society of Clinical Oncology ...poster session will take place from 8:00 am to 12,...mmune will,present the poster abstract entitled "P...
Other Medicine Technology:SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
Quatroloc Revision Hip System
A stable revision design with extensive sizes
Medicine Products: